rs183347428
Variant summary
Our verdict is Benign. Variant got -18 ACMG points: 2P and 20B. PM1BP4_StrongBP6_Very_StrongBS1BS2
The NM_000203.5(IDUA):c.667G>A(p.Asp223Asn) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.000331 in 1,598,148 control chromosomes in the GnomAD database, including 3 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign,other (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. D223Y) has been classified as Uncertain significance.
Frequency
Consequence
NM_000203.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -18 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
IDUA | NM_000203.5 | c.667G>A | p.Asp223Asn | missense_variant | 6/14 | ENST00000514224.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
IDUA | ENST00000514224.2 | c.667G>A | p.Asp223Asn | missense_variant | 6/14 | 2 | NM_000203.5 | P1 |
Frequencies
GnomAD3 genomes AF: 0.00199 AC: 303AN: 152004Hom.: 3 Cov.: 34
GnomAD3 exomes AF: 0.000363 AC: 80AN: 220268Hom.: 0 AF XY: 0.000238 AC XY: 29AN XY: 121962
GnomAD4 exome AF: 0.000156 AC: 226AN: 1446026Hom.: 0 Cov.: 34 AF XY: 0.000145 AC XY: 104AN XY: 719450
GnomAD4 genome AF: 0.00199 AC: 303AN: 152122Hom.: 3 Cov.: 34 AF XY: 0.00204 AC XY: 152AN XY: 74366
ClinVar
Submissions by phenotype
Mucopolysaccharidosis type 1 Benign:1Other:2
Benign, no assertion criteria provided | clinical testing | Natera, Inc. | Apr 23, 2020 | - - |
not provided, no classification provided | literature only | GeneReviews | - | Pseudodeficiency variants - |
other, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Dec 19, 2018 | - pseudodeficiency allele |
not provided Uncertain:1Benign:1
Uncertain significance, no assertion criteria provided | clinical testing | Mayo Clinic Laboratories, Mayo Clinic | May 16, 2017 | - - |
Benign, criteria provided, single submitter | clinical testing | GeneDx | Sep 28, 2018 | This variant is associated with the following publications: (PMID: 27939258, 27238910) - |
Inborn genetic diseases Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Ambry Genetics | Nov 19, 2021 | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at